Pyrexia, commonly known as fever, is a frequent clinical symptom indicating an underlying pathological condition. Despite its common occurrence, the management of fever often presents a challenge to clinicians due to its diverse etiology and clinical manifestations.
Pyrexia is a complex physiological response to disease, characterized by an elevation of body temperature above the normal range. It is primarily triggered by pyrogens, substances that stimulate the hypothalamus to increase the body's set point. These pyrogens can be either exogenous, like bacterial toxins, or endogenous, like cytokines released in response to inflammation or infection.
Effective management of pyrexia begins with a thorough clinical assessment. This includes a detailed history, physical examination, and appropriate investigations. The goal is to identify the source of the fever and any potential complications. Laboratory tests, imaging studies, and microbiological cultures may be required based on the clinical presentation.
Management of pyrexia involves both symptomatic treatment to reduce discomfort and targeted therapy to address the underlying cause. Antipyretics such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptomatic relief. However, the choice of antipyretic should be guided by the patient's overall clinical condition and potential side effects. Furthermore, if an infectious etiology is identified, specific antimicrobial therapy should be initiated promptly.
Continuous monitoring of the patient's temperature and response to treatment is crucial. Persistent or recurrent fever may indicate a need for reassessment or modification of the treatment plan. Regular follow-up visits are also vital to ensure complete resolution of the fever and to monitor for potential complications.
In conclusion, the management of pyrexia requires a comprehensive approach that includes assessment, diagnosis, treatment, and follow-up. By understanding the pathophysiology of fever and employing appropriate diagnostic and therapeutic strategies, clinicians can effectively manage this common but complex clinical symptom.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation